Use of oral enzymes in multiple sclerosis: Phenotyping of peripheral blood lymphocytes from MS patients under long-term treatment with orally administered hydrolytic enzymes

International Journal of Immunotherapy

Volumn 13, Issue 3-4, 1997, Pages 135-137

  Stauder, G ^a   Donnerstag, B ^b   Baumhackl, U ^c   Buschmans, E ^a  

^a Mucos Pharma   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Dept of Neurology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; HYDROLASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY; PHLOGENZYM; RUTOSIDE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PERIPHERAL LYMPHOCYTE; PHENOTYPE;

EID: 0031399930     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Neuhofer C. Enzymtherapie bei Multipler Sklerose. Hufeland-Journal, 2, 47, 1986.
2. Ransberger K., van Schalk W. Enzymtherapie bei Multipler Sklerose. Deutsches Arztemagazin, 26, 42, 1986.
3. Neuhofer C. Systemische Enzymtherapie bei Encephalomyelitis. Österreichische Zeitschrift für Allgemeinmedizin, 645, 702, 1991.
4. Baumhackl U., Födermair S. First Trends of a multicentric pilot study with hydrolytic enzymes in patients with Multiple Sclerosis, 8th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Barcelona, Oct. 23-24, 1992.
5. Lassmann H., Zimprich F., Rössler K., Vass K. Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev. Neurol., 147, 763, 1991.
6. Babsit S., Cook S.D., Rohowsky-Kochan C. Multiple Sclerosis: Immune responses and update on current therapies. Ann. Neural., 37, 87, 1995.
7. Olsson T. Role of cytokines in multiple sclerosis and autoimmune and experimental autoimmune encephalomyelitis, Eur. J. Neurol., 1, 7, 1994.
8. Cannella B., Raine S. The adhesion molecule and cytokine profile of multiple sclerosis. Ann. Neurol., 37, 424, 1995.
9. Yoo Y.K., Heo D.S., Hata K., van Thiel D.H., Whiteside D.L. Tumor infiltrating from human colon carcinomas. Gastroenterol., 98, 259, 1990.